Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II Study

OBJECTIVE: To investigate the efficacy and safety of bone marrow-derived mesenchymal stem cells (BM-MSCs) on chronic active antibody-mediated rejection (cABMR) in the kidney allograft. METHODS: Kidney recipients with biopsy-proven cABMR were treated with allogeneic third-party BM-MSCs in this open-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yongcheng, Chen, Xiaoyong, Zhang, Huanxi, Su, Qun, Peng, Yanwen, Fu, Qian, Li, Jun, Gao, Yifang, Li, Xirui, Yang, Shicong, Ye, Qianyu, Huang, Huiting, Deng, Ronghai, Li, Gang, Xu, Bowen, Wu, Chenglin, Wang, Jiali, Zhang, Xiaoran, Su, Xiaojun, Liu, Longshan, Xiang, Andy Peng, Wang, Changxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267917/
https://www.ncbi.nlm.nih.gov/pubmed/34248942
http://dx.doi.org/10.3389/fimmu.2021.662441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267917/
https://www.ncbi.nlm.nih.gov/pubmed/34248942
http://dx.doi.org/10.3389/fimmu.2021.662441

Ejemplares similares